Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer

Conditions

Breast Cancer

What is the purpose of this trial?

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy in different ways may kill any tumor cells that remain after surgery. It is not yet known whether whole breast radiation therapy is more effective than partial breast radiation therapy in treating breast cancer.

PURPOSE: This randomized phase III trial is studying whole breast radiation therapy to see how well it works compared to partial breast radiation therapy in treating women who have undergone surgery for ductal carcinoma in situ or stage I or stage II breast cancer.



Participation Guidelines

Age:
18 Years and older
Gender:
Female

Click here for detailed information about who can participate in this trial.


Sponsor:
National Cancer Institute (NCI)
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Radiation Therapy Oncology Group
Southwest Oncology Group
Dates:
March 2005
Last Updated:
December 1, 2011
Study HIC#:
0505027735

Clinicaltrials.gov ID: NCT00103181